DexCom, Inc.

Symbol: DXCM

NASDAQ

128.14

USD

Market price today

  • 78.2109

    P/E Ratio

  • 3.9105

    PEG Ratio

  • 50.96B

    MRK Cap

  • 0.00%

    DIV Yield

DexCom, Inc. (DXCM) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.63%

Operating Profit Margin

0.17%

Net Profit Margin

0.17%

Return on Assets

0.10%

Return on Equity

0.29%

Return on Capital Employed

0.13%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Devices
CEO:Mr. Kevin Ronald Sayer
Full-time employees:9500
City:San Diego
Address:6340 Sequence Drive
IPO:2005-04-14
CIK:0001093557

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

General Outlook

When we look at how much money they make before expenses, they keep 0.628% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.171%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.168%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.099% return, is a testament to DexCom, Inc.'s adeptness in optimizing resource deployment. DexCom, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.294%. Furthermore, the proficiency of DexCom, Inc. in capital utilization is underscored by a remarkable 0.133% return on capital employed.

Stock Prices

DexCom, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $128.74, while its low point bottomed out at $123.52. This variance in figures offers investors a lucid insight into the roller-coaster ride that is DexCom, Inc.'s stock market.

Liquidity Ratios

Analyzing DXCM liquidity ratios reveals its financial health of the firm. The current ratio of 289.84% gauges short-term asset coverage for liabilities. The quick ratio (243.50%) assesses immediate liquidity, while the cash ratio (53.39%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio289.84%
Quick Ratio243.50%
Cash Ratio53.39%

Profitability Ratios

DXCM profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 20.47% underscores its earnings before tax deductions. The effective tax rate stands at 17.87%, revealing its tax efficiency. The net income per EBT, 82.13%, and the EBT per EBIT, 119.46%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 17.14%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin20.47%
Effective Tax Rate17.87%
Net Income per EBT82.13%
EBT per EBIT119.46%
EBIT per Revenue17.14%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.90, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 386.05% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding243
Days of Inventory Outstanding152
Operating Cycle246.66
Days of Payables Outstanding70
Cash Conversion Cycle177
Receivables Turnover3.86
Payables Turnover5.24
Inventory Turnover2.40
Fixed Asset Turnover3.23
Asset Turnover0.59

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 2.06, and free cash flow per share, 1.50, depict cash generation on a per-share basis. The cash per share value, 7.42, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.21, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share2.06
Free Cash Flow per Share1.50
Cash per Share7.42
Operating Cash Flow Sales Ratio0.21
Free Cash Flow to Operating Cash Flow Ratio0.73
Cash Flow Coverage Ratio0.31
Short Term Coverage Ratio38.76
Capital Expenditure Coverage Ratio3.67
Dividend Paid and Capex Coverage Ratio3.67

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 39.96%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.15, we discern the balance between debt and equity financing. The long-term debt to capitalization, 53.35%, and total debt to capitalization, 53.55%, ratios shed light on its capital structure. An interest coverage of 32.10 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio39.96%
Debt Equity Ratio1.15
Long Term Debt to Capitalization53.35%
Total Debt to Capitalization53.55%
Interest Coverage32.10
Cash Flow to Debt Ratio0.31
Company Equity Multiplier2.89

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 9.38, provides a glimpse into top-line earnings distributed across each share. Net income per share, 1.40, reflects the portion of profit attributed to each share. The book value per share, 5.36, represents the net asset value distributed per share, while the tangible book value per share, 4.95, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share9.38
Net Income Per Share1.40
Book Value Per Share5.36
Tangible Book Value Per Share4.95
Shareholders Equity Per Share5.36
Interest Debt Per Share6.77
Capex Per Share-0.61

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 24.49%, indicates top-line expansion, while the gross profit growth, 21.55%, reveals profitability trends. EBIT growth, 52.79%, and operating income growth, 52.79%, offer insights into operational profitability progression. The net income growth, 58.70%, showcases bottom-line expansion, and the EPS growth, 59.09%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth24.49%
Gross Profit Growth21.55%
EBIT Growth52.79%
Operating Income Growth52.79%
Net Income Growth58.70%
EPS Growth59.09%
EPS Diluted Growth62.50%
Weighted Average Shares Growth-0.87%
Weighted Average Shares Diluted Growth-0.47%
Operating Cash Flow Growth11.80%
Free Cash Flow Growth68.00%
10-Year Revenue Growth per Share1568.04%
5-Year Revenue Growth per Share220.93%
3-Year Revenue Growth per Share83.91%
10-Year Operating CF Growth per Share22878.56%
5-Year Operating CF Growth per Share455.29%
3-Year Operating CF Growth per Share53.96%
10-Year Net Income Growth per Share1438.83%
5-Year Net Income Growth per Share489.40%
3-Year Net Income Growth per Share7.32%
10-Year Shareholders Equity Growth per Share1712.27%
5-Year Shareholders Equity Growth per Share185.04%
3-Year Shareholders Equity Growth per Share10.79%
Receivables Growth38.44%
Inventory Growth82.46%
Asset Growth16.19%
Book Value per Share Growth-2.11%
Debt Growth24.39%
R&D Expense Growth4.46%
SGA Expenses Growth18.52%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 49,926,440,000, captures the company's total value, considering both debt and equity. Income quality, 1.38, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.28, gauges operational efficiency, while the research and development to revenue, 13.96%, highlights investment in innovation. The ratio of intangibles to total assets, 2.55%, indicates the value of non-physical assets, and capex to operating cash flow, -31.61%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value49,926,440,000
Income Quality1.38
Sales General and Administrative to Revenue0.28
Research and Development to Revenue13.96%
Intangibles to Total Assets2.55%
Capex to Operating Cash Flow-31.61%
Capex to Revenue-6.53%
Capex to Depreciation-127.20%
Stock-Based Compensation to Revenue4.16%
Graham Number13.01
Return on Tangible Assets8.87%
Graham Net Net-1.17
Working Capital2,869,900,000
Tangible Asset Value1,908,900,000
Net Current Asset Value230,000,000
Invested Capital1
Average Receivables850,400,000
Average Payables589,100,000
Average Inventory433,150,000
Days Sales Outstanding100
Days Payables Outstanding76
Days of Inventory On Hand153
ROIC9.77%
ROE0.26%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 22.25, and the price to book ratio, 22.25, reflect the market's valuation relative to the company's book value. The price to sales ratio, 13.40, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 87.33, and price to operating cash flows, 62.32, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio22.25
Price to Book Ratio22.25
Price to Sales Ratio13.40
Price Cash Flow Ratio62.32
Price Earnings to Growth Ratio3.91
Enterprise Value Multiple56.75
Price Fair Value22.25
Price to Operating Cash Flow Ratio62.32
Price to Free Cash Flows Ratio87.33
Price to Tangible Book Ratio23.16
Enterprise Value to Sales13.78
Enterprise Value Over EBITDA54.46
EV to Operating Cash Flow66.70
Earnings Yield1.13%
Free Cash Flow Yield1.07%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of DexCom, Inc. (DXCM) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 78.211 in 2024.

What is the ticker symbol of DexCom, Inc. stock?

The ticker symbol of DexCom, Inc. stock is DXCM.

What is company IPO date?

IPO date of DexCom, Inc. is 2005-04-14.

What is company current share price?

Current share price is 128.140 USD.

What is stock market cap today?

The market cap of stock today is 50959227760.000.

What is PEG ratio in 2024?

The current 3.911 is 3.911 in 2024.

What is the number of employees in 2024?

In 2024 the company has 9500.